探究多基因易感性与电休克治疗疗效之间的关联
该研究纳入3个国家共288例重性抑郁发作患者,分析重性抑郁障碍、精神分裂症(SCZ)、跨疾病及抗抑郁药反应的多基因风险评分(PRS)与电休克治疗(ECT)疗效的关联。在通过质量控制的266例受试者中,PRS-SCZ与17项汉密尔顿抑郁量表评分的更大下降呈正相关(最优p值阈值=.05,R2=6.94%,p<.0001),且与缓解正相关(R2=4.63%,p=.0018),其他PRS在预设Bonferroni校正显著性阈值下与量表评分变化无关联。
要点
- 在266例通过质量控制的患者中,PRS-SCZ与ECT后17项汉密尔顿抑郁量表评分下降更大呈正相关(R2=6.94%,p<.0001)。
- PRS-SCZ与缓解正相关(R2=4.63%,p=.0018),在爱尔兰、比利时、荷兰3国结果一致。
- 其他PRS在预设Bonferroni校正显著性阈值下与汉密尔顿抑郁量表评分变化无关联。
核心结论
- 研究发现PRS-SCZ与ECT疗效之间存在线性关联。
- 作者认为,尽管在ECT临床决策中采用PRS为时过早,但这些发现强化了PRS-SCZ与精神科治疗反应相关的定位。
研究设计与样本
- 研究纳入来自3个国家的288例重性抑郁发作患者。
- 主要结局为ECT治疗前后17项汉密尔顿抑郁量表评分的变化,次要结局为反应和缓解。
- 采用以PRS为自变量并纳入若干协变量的回归分析,报告最优p值阈值下的解释方差(R2)。
主要发现
- 在通过质量控制的266例受试者中,PRS-SCZ与更大的汉密尔顿抑郁量表评分下降呈正相关(最优p值阈值=.05,R2=6.94%,p<.0001)。
- 该关联在各国一致:爱尔兰(R2=8.18%,p=.0013)、比利时(R2=6.83%,p=.016)、荷兰(R2=7.92%,p=.0077)。
- PRS-SCZ与缓解正相关(R2=4.63%,p=.0018)。
- 敏感性和亚组分析证实了结果,包括无精神病性特征的重性抑郁发作(R2=4.42%,p=.0024)和仅单相重性抑郁发作(R2=9.08%,p<.0001)。
- 其他PRS在预设Bonferroni校正显著性阈值下与汉密尔顿抑郁量表评分变化无关联。
临床怎么用
- 作者认为,在ECT临床决策中采用PRS为时过早。
- 作者认为,这些发现强化了PRS-SCZ与精神科治疗反应相关的定位。
局限性
- 作者认为,在ECT临床决策中采用PRS为时过早。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Electroconvulsive therapy (ECT) is the most effective treatment for severe major depressive episodes (MDEs). Nonetheless, firmly established associations between ECT outcomes and biological variables are currently lacking. Polygenic risk scores (PRSs) carry clinical potential, but associations with treatment response in psychiatry are seldom reported. Here, we examined whether PRSs for major depressive disorder, schizophrenia (SCZ), cross-disorder, and pharmacological antidepressant response are associated with ECT effectiveness. METHODS: A total of 288 patients with MDE from 3 countries were included. The main outcome was a change in the 17-item Hamilton Depression Rating Scale scores from before to after ECT treatment. Secondary outcomes were response and remission. Regression analyses with PRSs as independent variables and several covariates were performed. Explained variance (R2) at the optimal p-value threshold is reported. RESULTS: In the 266 subjects passing quality control, the PRS-SCZ was positively associated with a larger Hamilton Depression Rating Scale decrease in linear regression (optimal p-value threshold = .05, R2 = 6.94%, p < .0001), which was consistent across countries: Ireland (R2 = 8.18%, p = .0013), Belgium (R2 = 6.83%, p = .016), and the Netherlands (R2 = 7.92%, p = .0077). The PRS-SCZ was also positively associated with remission (R2 = 4.63%, p = .0018). Sensitivity and subgroup analyses, including in MDE without psychotic features (R2 = 4.42%, p = .0024) and unipolar MDE only (R2 = 9.08%, p < .0001), confirmed the results. The other PRSs were not associated with a change in the Hamilton Depression Rating Scale score at the predefined Bonferroni-corrected significance threshold. CONCLUSIONS: A linear association between PRS-SCZ and ECT outcome was uncovered. Although it is too early to adopt PRSs in ECT clinical decision making, these findings strengthen the positioning of PRS-SCZ as relevant to treatment response in psychiatry.
引用
- Luykx JJ, Loef D, Lin B, et al. Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy Effectiveness. Biol Psychiatry. 2021. PMID: 34955169. doi:10.1016/j.biopsych.2021.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。